Atlas Trials

Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature

Clinical trial NCT01756547 · UNKNOWN

Trial details

NCT number
NCT01756547
Sponsor
Juan A. Arnaiz
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Nephrocalcinosis
Start date
2013-01-01
Primary completion
2013-12-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.